title: Preparation of methotrexate-loaded, large, highly-porous PLLA microspheres by a high-voltage electrostatic antisolvent process.
abstract: A high-voltage (10 kV) electrostatic antisolvent process was used to prepare methotrexate (MTX)-loaded, large, highly-porous poly-L-lactide (PLLA) microspheres. MTX solution in dimethyl sulfoxide (DMSO) and PLLA solution in dichloromethane (DCM) were homogeneously mixed, and then ammonium bicarbonate (AB) aqueous solution was added. The mixed solution was emulsified by ultrasonication with Pluronic F127 (PF127) as an emulsion stabilizer. The emulsion was electrosprayed by the specific high-voltage apparatus and dropped into a 100 mL of ethanol, which acted as an antisolvent for the solute and extracted DMSO and DCM, causing the co-precipitation of PLLA and MTX, thus forming microspheres with AB aqueous micro-droplets uniformly inlaid. The obtained MTX-PLLA microspheres were subsequently lyophilized to obtain large, highly-porous MTX-PLLA microspheres, which exhibited an identifiable spherical shape and a rough surface furnished with open pores, with a mean particle size of 25.0 μm, mass median aerodynamic diameter of 3.1 ± 0.2 μm, fine-particle fraction of 57.1 ± 1.6 %, and porosity of 81.8 %; furthermore, they offered a sustained release of MTX. X-ray diffraction and Fourier transform-infrared spectra revealed that no crystallinity or alteration of chemical structure occurred during the high-voltage electrostatic antisolvent process, which in this study was proved to have great potential for preparing highly-porous drug-loaded polymer microspheres for use in pulmonary drug delivery.
authors: College of Chemical Engineering, Huaqiao University, Xiamen, 361021, China. azchen@hqu.edu.cn
authors: Ai-Zheng
authors: AZ
authors: Chen
authors: Yue-Mei
authors: YM
authors: Yang
authors: Shi-Bin
authors: SB
authors: Wang
authors: Guang-Ya
authors: GY
authors: Wang
authors: Yuan-Gang
authors: YG
authors: Liu
authors: Qing-Qing
authors: QQ
authors: Sun
mesh_terms: D004337:Drug Carriers / Q000138:chemical synthesis* / Q000737:chemistry / Q000493:pharmacokinetics; D004339:Drug Compounding / Q000379:methods*; D016503:Drug Delivery Systems; D008727:Methotrexate / Q000008:administration & dosage* / Q000493:pharmacokinetics; D008863:Microspheres; D008954:Models, Biological; D010316:Particle Size; D011091:Polyesters / Q000138:chemical synthesis / Q000737:chemistry*; D016062:Porosity; D012997:Solvents / Q000494:pharmacology; D017550:Spectroscopy, Fourier Transform Infrared; D055672:Static Electricity; D013499:Surface Properties; D014961:X-Ray Diffraction
chemical_list: D004337:Drug Carriers; D011091:Polyesters; D012997:Solvents; C033616:poly(lactide); D008727:Methotrexate
references: J Control Release. 2006 Jul 20;113(3):216-25
references: 16797098
references: J Control Release. 2012 Jul 20;161(2):214-24
references: 22192571
references: J Control Release. 2005 Dec 10;110(1):34-48
references: 16225952
references: Int J Pharm. 2006 Aug 31;320(1-2):30-6
references: 16697538
references: Biomaterials. 2009 Apr;30(10):1947-53
references: 19135245
references: J Biomech Eng. 2009 Jul;131(7):074515
references: 19640151
references: J Control Release. 2011 Oct 30;155(2):289-95
references: 21843562
references: Biomaterials. 2004 Nov;25(25):5649-58
references: 15159081
references: Int J Pharm. 2004 Jun 18;278(1):187-95
references: 15158961
references: Biotechnol Bioeng. 2007 Aug 1;97(5):1278-90
references: 17216662
references: J Control Release. 2012 Mar 10;158(2):329-35
references: 22063006
references: J Colloid Interface Sci. 2010 Mar 1;343(1):125-33
references: 20022337
references: J Control Release. 2001 Jun 15;73(2-3):121-36
references: 11516493
references: Int J Pharm. 2007 Aug 16;341(1-2):195-206
references: 17467934
references: Int J Pharm. 2011 Jul 15;413(1-2):51-62
references: 21530623
references: Int J Pharm. 2009 Jan 5;365(1-2):12-7
references: 18786624
references: J Control Release. 2008 Jan 4;125(1):1-15
references: 18022722
references: Pharm Res. 2007 Mar;24(3):411-37
references: 17245651
references: J Control Release. 2006 May 15;112(2):167-74
references: 16542746
references: Eur J Pharm Sci. 2006 Dec;29(5):367-74
references: 16952451
references: J Control Release. 2007 Aug 16;121(1-2):100-9
references: 17604870
references: J Control Release. 2012 Apr 10;159(1):14-26
references: 22154931
references: J Control Release. 2011 Feb 28;150(1):56-62
references: 21070826
references: Eur J Pharm Sci. 2010 Sep 11;41(1):60-70
references: 20510360
references: J Biotechnol. 2005 Apr 20;117(1):99-109
references: 15831251
references: J Control Release. 2012 Apr 10;159(1):128-34
references: 22226774
references: Drug Discov Today Technol. 2012 Summer;9(2):e71-e174
references: 24064274
references: Mol Pharm. 2012 Feb 6;9(2):290-8
references: 22149217
references: J Control Release. 2010 Aug 17;146(1):61-7
references: 20553775
references: Int J Pharm. 2007 Mar 21;333(1-2):103-11
references: 17079101
references: Int J Pharm. 2007 Mar 21;333(1-2):5-9
references: 17296275